▲ Peaking
Health
Alzheimer's: BCG vaccine may reshape brain immune response
New clinical trial data suggests the BCG tuberculosis vaccine may reduce Alzheimer's risk by reprogramming the brain's immune environment.
1 trends tracked about this subject — the full history, oldest to newest below.
New clinical trial data suggests the BCG tuberculosis vaccine may reduce Alzheimer's risk by reprogramming the brain's immune environment.